Incidence of chromosome numerical changes in multiple myeloma: Fluorescence in situ hybridization analysis using 15 chromosome-specific probes

American Journal of Pathology

Volumn 149, Issue 1, 1996, Pages 153-161

  Tabernero, Dolores ^a   San Miguel, Jesús F ^b   García Sanz, Ramón ^b   Nájera, Luisa ^a   García Isidoro, María ^a   Pérez Simón, José A ^b   González, Marcos ^b   Wiegant, Joop ^c   Raap, Anton K ^c   Orfão, Alberto ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; CALCULATION; CHROMOSOME LOSS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MONOSOMY; MULTIPLE MYELOMA; NUMERICAL CHROMOSOME ABERRATION; PLASMA CELL; PRIORITY JOURNAL; TRISOMY;

AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 7; DNA PROBES; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; TRISOMY;

EID: 8944237001     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Dewald GW, Kyle RA, Hicks GA, Greipp PRP: The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 1985, 66:380-387
2. Durie BGM, Vela EE, Baum V: Cytogenetics abnormalities in multiple myeloma. Epidemiology and Biology in Multiple Myeloma. New York, Springer-Verlag, 1991, pp 137-141
3. Laï JL, Zandecki M, Mary JY, Bernardi F, Izydorczyk V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T: Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood 1995, 85:2490-2497
4. Sawyer JR, Waldron JA, Jagannath S, Barlogie B: Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet (in press)
5. Latreille J, Barlogie B, Johnston DA, Drewinko B, Alexanian R: Ploidy and proliferative characteristics in monoclonal gammopathies. Blood 1982, 59:43-51
6. Shimazaki C, Gotoh H, Ashihara E, Oku N, Inaba T, Murakami S, Itoh K, Ura Y, Nakagawa M, Fujita N: Immunophenotype and DNA contents of myeloma cells in primary plasma cell leukemia. Am J Hematol 1992, 39:159-162
7. García-Sanz R, Orfão A, González M, Moro MJ, Hernández JM, Ortega F, Borrego D, Carnero M, Casanova F, Jiménez R, Portero JA, San Miguel JF: Prognosic implications of DNA aneuploidy in a series of 156 untreated MM patients. Br J Haematol 1995, 90:106-112
8. Shankey TV, Ravinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, Mayall BH, Wheeless LL: Guidelines for implementation of clinical DNA cytometry. Cytometry 1993, 14:472-477
9. Orfão A, González M, Ciudad J, López-Berges MC, López A, Vidriales B, Macedo A, San Miguel JF: Cell cycle and DNA aneuploidy: biological bases and terminology. DNA Cytometric Analysis. Edited by A. Sampedro, A Orfão. Oviedo, Spain, Ediciones de la Universidad de Oviedo, 1993, p 13-24
10. Cooke HJ, Hindley M: Cloning of human satellite III DNA: different components are on different chromosomes. Nucleic Acids Res 1979, 6:3177-3197
11. Prosser J, Frommer M, Paul C, Vincent PC: Sequence relationship of three human satellite DNAs. J Mol Biol 1986, 187:145-155
12. Grady D, Ratliff RL, Robinson DL, McCanlies EC, Meyne J, Moyzis RK: Highly conserved repetitive DNA sequences are present at human centromeres. Proc Natl Acad Sci USA 1992, 89:1695-1699
13. Chronic Leukemia-Myeloma Task Force, National Cancer Institute: Proposed guidelines for protocol studies. II. Plasma cell myeloma. Cancer Chemother Rep 1973, 4:145-158
14. Durie BGM, Salmon SE: A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 1975, 36:842-854
15. Bladé J, San Miguel JF, Alcalá A, Maldonado J, Sanz MA, García-Conde J, Moro MJ, Alonso C, Besalduch J, Zubizarreta A, Besses C, González Brito G, Hernández-Martín J, Fernández-Calvo J, Rubio D, Ortega F, Jiménez R, Colominas P, Faura MV, Font L, Tortosa J, Domingo A, Fontanillas M, Rozman C, Estapé C: Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patients. J Clin Oncol 1993, 11:1165-1171
16. San Miguel JF, González M, Gascón A, Moro MJ, Hernández JM, Ortega F, Jiménez R, Guerras L, Romero M, Casanova F, Sanz MA, Sánchez J, Portero JA, Orfão A: Immunophenotype heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Br J Haematol 1991, 77:185-190
17. Orfão A, García-Sanz R, López-Berges MC, Vidriales MB, González M, Caballero MD, San Miguel JF: A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique. Cytometry 1994, 17: 332-339
18. Tabernero MD, San Miguel JF, García VL, García-Isidoro M, Wiegnant J, Ciudad J, González M, Ríos A, Raap A, Orfão A: Clinical, biological and immunophenotypical characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization. Cytometry 1995, 22:217-222
19. Wiegant J, Ried T, Nederlof PM, Van der Ploeg M, Tanke HJ, Raap AK: In situ hybridization with fluoresceinated DNA Nucleic Acids Res 1991, 19: 3237-3241
20. Arnoldus EPJ, Noordemeer IA, Peters ACB, Boormolen JHC, Bots TAM, Raap AK, Van der Ploeg M: Interphase cytogenetics of brain tumors. Genes Chromosomes & Cancer 1991, 3:101-107
21. Vindelov LL, Christehnsen IBJ, Jensen G, Nissen NI: Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis: results obtained by a set of methods for sample storage, staining and internal standardization. Cytometry 1983, 3:332-338
22. Ferti A, Panani A, Arakapis G, Raptis S: Cytogenetic studies in multiple myeloma. Cancer Genet Cytogenet 1994, 12:247-253
23. Facon T, Laï JL, Nataf E, Preudhomme C, Zandecki M, Hammad M, Wattel E, Jouet JP, Bauters F: Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report of 46 patients. Br J Haematol 1993, 84:743-745
24. Weh HJ, Gutensohn K, Selbach J, Kruse R, Waker-Backhaus G, Seeger D, Fiedler W, Fett W, Hossfeld DK: Karyotype in multiple myeloma and plasma cell leukaemia. Eur J Cancer 1993, 29A:1269-1273
25. Gould J, Alexanian R, Goodrace A, Pathak S, Hecht B, Barlogie B: Plasma cell karyotype in multiple myeloma Blood 1988, 71:453-456
26. San Miguel JF, García-Sanz R, González M, Moro MJ, Hernández JM, Ortega F, Borrego D, Carnero M, Casanova F, Jiménez R, Portero JA, Orfão A: A new staging system for multiple myeloma based on the number of S-phase plasma cells. Blood 1995, 85:448-455
27. Anastasi J, LeBeau MM, Vardiman JW, Fernald AA, Larson RA, Rowley JD: Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. Blood 1992, 79:1796-1801
28. Dohner H, Polh S, Bulgay-Mörschel M, Stilgenbauer S, Bentz M, Lichter P: Trisomy 12 in chronic lymphocytic leukemia: a metaphase and interphase cytogenetic analysis. Leukemia 1993, 7:516-520
29. Poddinghe PJ, Moesker O, Smeets D, Awwad BH, Ramaekers FC, Hopman AH: Interphase cytogenetics of hematological cancer: comparison of classical karyotyping and in situ hybridization using a panel of eleven chromosome-specific DNA probes. Cancer Res 1991, 51:1959-1967
30. Kibbelaar RE, van Kamp H Dreef EJ, Wessels JW, Beverstock GC, Raap AK, Fibbe WE. den Ottolander GJ, Kluin PM: Detection of trisomy 8 in hematological disorders by in situ hybridization Cytogenet Cell Genet 1991, 56:132-136
31. Drach J, Angerler J, Schuster J, Nowotny H, Scherrer R, Jäger U, Heizn R, Geissler K, Lechner K, Ludwig H, Huber H: Interphase cytogenetic studies in multiple myeloma and monoclonal gammopathy of undetermined significance. Blood 1994, 84:677
32. Facon T, Flactif M, Zandecki M, Bernardi F, Bauters F, Laï JL: Fluorescence in situ hybridization improves the detection of cytogenetic abnormalities in multiple myeloma. Blood 1994, 84:2076
33. Hirama T, Koeffler HP: Role of the cyclin-dependent kinase inhibitors in the development of cancer Blood 1995, 86:841-854
34. Lee WH, Bookstein RE, Lee EYHP: Molecular biology of the human retinoblastoma gene. Tumour Supressor Genes. Edited by G. Klein. New York, Marcel Dekker, 1990, pp 169-199
35. Heim S, Mitelman F: Chronic lymphoproliferative disorders. Cancer Cytogenetics. Edited by R. Alan. New York, Liss, 1987, pp 175-180
36. Atkin NB: Chromosome 1 aberrations in cancer. Cancer Genet Cytogenet 1986, 21:279-285
37. Olah E, Balogh E, Kovaks I, Kiss A: Abnormalities of chromosome 1 in relation to human malignant disease. Cancer Genet Cytogenet 1989, 43:179-194
38. Façon T, Lai JL, Nataf E, Preudhomme C, Zandecki M, Hammad M, Wattel E, Jonet JP, Bauters F: Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma. Br J Haematol 1993, 84:743-745
39. Hagemeijer A: Chromosome abnormalities in CML. Bailliere's Clinical Hematology: Chronic Myeloid Leukemia. Edited by JM Goloman. London, Bailliere's Tindall, 1987, pp 963-981
40. Nowell PC, Besa EC: Prognostic significance of single chromosome abnormalities in preleukemic states. Cancer Genet Cytogenet 1989, 42:1-7